Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials.
第一作者:
Kayvon,Modjarrad
第一单位:
Walter Reed Army Institute of Research, Silver Spring, MD, USA.
作者:
主题词
抗体, 中和(Antibodies, Neutralizing);抗体, 病毒(Antibodies, Viral);双盲法(Double-Blind Method);人类(Humans);病毒疫苗(Viral Vaccines)
DOI
10.1016/S0140-6736(17)33106-9
PMID
29217375
发布时间
2024-09-22
- 浏览11

Lancet (London, England)
563-571页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文